Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Healthcare Medical Devices
Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).


TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Graham!!
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(335)
•••
Comment by O12009on Jun 08, 2021 8:17pm
270 Views
Post# 33352786

RE:RE:RE:RE:Graham!!

RE:RE:RE:RE:Graham!!
Yajne wrote: It's amazing wk how the 'parade watchers' with no skin in the game (unless they call time spent writing their bashing posts as 'sweat equity') keep pronouncing VPT dead and yet there continues to be much life as displayed in the trading today. I guess a bunch of true investors don't agree with the parade watcher(s). 

woundedknee wrote:
You are right about where I got back in to this company. I did make a good profit getting out at that price previously and really only get emotional when I read repetitive postings from posters like yourself. Data is out the window on spec stocks so quit that BS. I honestly have no idea why you are here. You seem to be well trained and obviously have graduated from bashing for dummies to bashing 101. Still you have a long way to go, but keep trying.




Garham has a 9 to 5 job so don't expect to hear from him tonight 

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities